Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice.
Veronika Pohořalá, Martin Kuchař, Rainer Spanagel, Rick E Bernardi
Neuroscience November 1, 2024 DOI: 10.1016/j.neuroscience.2024.09.006 via PubMed
Summary
AI-generated from the abstractPsilocybin administered immediately after extinction training did not reduce cue-induced cocaine-seeking in male and female mice or rats. In mice (16 female, 19 male) and rats (24 female, 23 male) that had learned to self-administer cocaine, psilocybin injections (1.0 mg/kg in mice; 1.0 or 2.5 mg/kg in rats) following extinction trials failed to attenuate reinstatement of drug-seeking when cues were presented. Both species and sexes showed significant cue-induced reinstatement regardless of psilocybin treatment. The findings indicate that psilocybin, at the doses and regimen tested, is ineffective in altering cocaine-seeking behavior in these animal models, leaving open whether other conditions might prove useful.
Study at a glance
| Characteristics | Preclinical experimental study Peer reviewed |
|---|---|
| Sample size | 82 |
| Population | Male and female mice and rats |
| Intervention | Psilocybin |
| Dose | 1.0 mg/kg (mice); 1.0 mg/kg or 2.5 mg/kg (rats) |
| Duration | 8-day self-administration and extinction (mice); 15-day self-administration and extinction (rats) |
| Topics | Addiction Psilocybin |
| Keywords | Addiction treatment Psychedelic research Substance abuse Cocaine dependence Animal studies |
| Citations | 3 |
| Key finding | Psilocybin did not attenuate cue-induced reinstatement of cocaine-seeking in either mice or rats. |
Abstract
There are currently no pharmacological treatments for cocaine use disorder. Recently there has been a great deal of interest in the potential of psychedelic drugs such as psilocybin to treat psychiatric disorders. Human studies have indicated that a single administration of psilocybin can have long-lasting effects. Few preclinical studies have examined a role for psilocybin in addiction models. The goal of the current study was to determine whether psilocybin would enhance extinction following cocaine self-administration in male and female mice and rats and thus result in an attenuation of cue-induced drug-seeking. In experiments in mice, 16 female and 19 male mice underwent 8d of cocaine self-administration (0.5 mg/kg/infusion) and extinction training. Immediately following extinction trials, mice were injected with vehicle or 1.0 mg/kg psilocybin. Following the conclusion of extinction training, mice were tested for cue-induced reinstatement. In experiments in rats, 24 female and 23 male rats underwent 15d of cocaine self-administration (0.8 mg/kg/infusion) and extinction training. Immediately following extinction trials, rats were injected with vehicle, 1.0 mg/kg psilocybin, or 2.5 mg/kg psilocybin. Following the conclusion of extinction training, rats were tested for cue-induced reinstatement. Psilocybin administered following extinction trials had no effect, as both female and male mice and rats demonstrated significant cue-induced reinstatement. These data suggest that psilocybin is ineffective at altering cocaine-seeking behavior in the paradigm and doses used in the current study. It remains to be seen whether treatment with psilocybin under different conditions may be useful in the long-standing goal of finding pharmacotherapies to treat CUD.